Locations:
SearchAdvertisement
Slower drug elimination from the body among females may impact safety and efficacy
Optimized responses in transplant- and CAR T-cell therapy-eligible patients
Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC
Patients with a prior history of VTA are at an increased risk of subsequent incidents, despite treatment with therapeutic anticoagulation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Driving advances in cancer care
Unique molecular features found in young-onset disease
Retrospective study aims to better stratify risk of disease recurrence
Timely referral to hospice care reduces emergency room admissions
Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia
Distinct molecular features found in five subtypes of disease
Advertisement
Advertisement